Singapore Markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
40.60-0.06 (-0.16%)
As of 10:26AM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close40.66
Bid40.53 x 1400
Ask40.54 x 1800
Day's range40.50 - 40.85
52-week range39.23 - 56.32
Avg. volume22,881,413
Market cap227.872B
Beta (5Y monthly)0.58
PE ratio (TTM)23.78
EPS (TTM)1.71
Earnings date01 May 2023 - 05 May 2023
Forward dividend & yield1.64 (3.76%)
Ex-dividend date26 Jan 2023
1y target est52.81
  • Yahoo Finance

    Moderna CEO faces Sen. Sanders in COVID-19 vaccine pricing hearing Wednesday

    Moderna CEO Stéphane Bancel is set to face Sen. Bernie Sanders to defend the company's fast growth and planned price hike of its COVID-19 vaccine.

  • Business Wire

    Pfizer Invites Public to View and Listen to Webcast of May 2 Conference Call with Analysts

    NEW YORK, March 21, 2023--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Tuesday, May 2, 2023. The purpose of the call is to provide an update on Pfizer’s results, as reflected in the company’s First Quarter 2023 Performance Report, to be issued that morning.

  • Motley Fool

    Pfizer Has Another Blockbuster on the Horizon, but That's Not All

    Over the past year, Pfizer (NYSE: PFE) made a series of acquisitions, even announcing at one point that it planned to remain "very active in deal-making." On March 13, Pfizer announced the planned blockbuster acquisition of cancer specialist Seagen (NASDAQ: SGEN) for a massive $43 billion in cash. This move, expected to close by year-end or early 2024, will likely improve Pfizer's prospects, and it is only the latest in a series of important and successful strategic decisions the company's management has made.